Virtually Assisted Home Rehabilitation After Acute Stroke-2
Launched by THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER, HOUSTON · Feb 20, 2023
Trial Information
Current as of May 14, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Informed consent provided by the subject or legally authorized representative.
- • Diagnosed with hemorrhagic or ischemic stroke
- • Pre-stroke mRS is less than 3
- • Qualifying Stroke Event must be confirmed by CT or MRI
- • Recommended to participate in self-guided or in-person rehabilitation activities by a physician or rehabilitation therapist
- • Must have sufficient cognitive and language abilities to comprehend verbal commands and to carry out the study assessments
- • Able to access the internet
- • Mild-moderate impairments in motor or cognitive function
- Exclusion Criteria:
- • History of neurological or other disease resulting in significant functional impairment (e.g. Parkinson's disease, motor neuron disease, moderate dementia, arthritis, contractures or fixed anatomical abnormality).
- • Subjects with a severe comorbid disorder that has reasonable likelihood of limiting survival to less than 6 months.
- • Any other conditions that, in the opinion of the investigators, would preclude safe and/or effective participation.
About The University Of Texas Health Science Center, Houston
The University of Texas Health Science Center at Houston (UTHealth) is a leading academic institution dedicated to advancing health through education, research, and clinical practice. As a prominent sponsor of clinical trials, UTHealth leverages its extensive resources and expertise in biomedical research to facilitate innovative studies aimed at improving patient outcomes. The institution is committed to fostering a collaborative environment that promotes scientific discovery and the translation of research findings into effective healthcare solutions, all while adhering to the highest ethical standards and regulatory guidelines. With a multidisciplinary approach, UTHealth plays a critical role in addressing complex health challenges and enhancing the quality of life in diverse communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Houston, Texas, United States
Patients applied
Trial Officials
Sean Savitz, MD
Principal Investigator
The University of Texas Health Science Center, Houston
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials